Revisto is a leading AI-powered platform revolutionizing the medical, legal, and regulatory (MLR) review process for pharmaceutical marketing materials. Based in Austin, Texas, Revisto leverages cutting-edge AI technology and industry expertise to streamline marketing operations, reduce costs, and eliminate compliance risks for life sciences companies. By optimizing the release cycle and improving quality and consistency, Revisto plays a pivotal role in enabling the next generation of data-driven, personalized and engaging life sciences marketing.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/18/24 | $4,000,000 | Seed |
Arkin Digital Health Eli Lilly and Company LiveOak Venture Partners  Tau Ventures | undisclosed |
